Company / EPS (Diluted)
Integra Lifesciences Holdings EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.84
FY2025
5-year range
$0.58 / $2.16
FY2021-FY2025
Trend
-61.1%
vs FY2024
Sector context
#79 of 159
Health Care
What the data says
At $0.84, Integra Lifesciences Holdings's eps (diluted) ranks #79 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.05 in FY2017 to $2.16 in FY2024.
Based on SEC 10-K filings.
0.84 in FY2025 with a 5-year CAGR of +3.1%.
Declined from $1.98 to $0.84 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
#79 of 159 in Health CareTop 50% of 159This company $0.84 Sector average $1.67
▼
-49.6% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 61.1% year-over-year.
- Ranks #79 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.84 | -61.1% |
| FY2024 | $2.16 | +9.1% |
| FY2023 | $1.98 | +26.1% |
| FY2022 | $1.57 | +170.7% |
| FY2021 | $0.58 | -19.4% |
| FY2020 | $0.72 | -12.2% |
| FY2019 | $0.82 | -12.8% |
| FY2018 | $0.94 | +1980.0% |
| FY2017 | -$0.05 | -109.6% |
| FY2016 | $0.52 | +170.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026